NeuroMed7 is a topical anesthetic containing 4% lidocaine that provides rapid onset of anesthesia within 15-20 minutes. It is designed to improve skin absorption and provide a medium duration of efficacy of around 60 minutes. NeuroMed7 can be used for minor procedures like injections, laser treatments, and hair removal. It is applied as a thin layer to the skin and rubbed in until fully absorbed to block nerve impulses and reduce pain. When used as directed, NeuroMed7 is a safe and cost-effective option to reduce pain from minor medical procedures.
NeuroMed7 is an OTC Topical Anesthetic with uses that include local anesthesia prior to:
Injections
Immunizations
Venipuncture
Minimally invasive procedures
Cosmetic/aesthetic procedures
Also post procedural analgesia
NeuroMed7 is a formula combination of the topical anesthetic, lidocaine HCl 4% and trans-dermal penetration enhancers created to promote a rapid onset of action and trans-dermal penetration
Benefits include:
Rapid onset of action
trans-dermal penetration
Affordable cost
Clinical size and multi-dose packaging
NeroMed7 is a rapid-onset topical anesthetic. It can be used as a pre-procedural, local, topical anesthetic for injections, veni-puncture and other minimally invasive dermal instrumentation procedures.
Pharmacy compounding - Importance, Non sterile compounding and Sterile compounding, Regulations of US Pharmacoepia, Compounded Products
For any suggestions and questions regarding this ppt please comment below.
NeuroMed7 is an OTC Topical Anesthetic with uses that include local anesthesia prior to:
Injections
Immunizations
Venipuncture
Minimally invasive procedures
Cosmetic/aesthetic procedures
Also post procedural analgesia
NeuroMed7 is a formula combination of the topical anesthetic, lidocaine HCl 4% and trans-dermal penetration enhancers created to promote a rapid onset of action and trans-dermal penetration
Benefits include:
Rapid onset of action
trans-dermal penetration
Affordable cost
Clinical size and multi-dose packaging
NeroMed7 is a rapid-onset topical anesthetic. It can be used as a pre-procedural, local, topical anesthetic for injections, veni-puncture and other minimally invasive dermal instrumentation procedures.
Pharmacy compounding - Importance, Non sterile compounding and Sterile compounding, Regulations of US Pharmacoepia, Compounded Products
For any suggestions and questions regarding this ppt please comment below.
TOPICAL ANESTHETIC FOR COSMETIC PROCEDURES
NeuroMed7 is a topical, local anesthetic that can be used for a variety of procedures to improve patient comfort and satisfaction
NeuroMed7 is a rapid onset of action OTC topical anesthetic that contains a combination of lidocaine HCl 4% with trans-dermal penetration/absorption enhancers
It can be used as a topical anesthetic prior to a variety of medical procedures including:
Injections
Trigger point injections
immunizations
Myo-facial paralyzing injections (BOTOX therapy)
Dermal fillers
Minimally invasive procedures
Venipuncture
Can also be used for post procedural analgesia
Can be used to mitigate pain, itch and burn related to cutaneous manifestations of a variety of conditions
Safe and effective concentration of lidocaine HCl
Rapid onset of action
trans-dermal penetration/absorption enhanced
OTC
Affordable pricing
Medical Spa (MedSpa) directors and workers should be aware of the FDA laws and policies that govern their industry, including those of their primary vendors. This rule may serve to warn directors and clinicians in this and other medical practices the risks of working with those compound pharmacies that do not comply.
TOPICAL ANESTHETIC FOR COSMETIC PROCEDURES
NeuroMed7 is a topical, local anesthetic that can be used for a variety of procedures to improve patient comfort and satisfaction
NeuroMed7 is a rapid onset of action OTC topical anesthetic that contains a combination of lidocaine HCl 4% with trans-dermal penetration/absorption enhancers
It can be used as a topical anesthetic prior to a variety of medical procedures including:
Injections
Trigger point injections
immunizations
Myo-facial paralyzing injections (BOTOX therapy)
Dermal fillers
Minimally invasive procedures
Venipuncture
Can also be used for post procedural analgesia
Can be used to mitigate pain, itch and burn related to cutaneous manifestations of a variety of conditions
Safe and effective concentration of lidocaine HCl
Rapid onset of action
trans-dermal penetration/absorption enhanced
OTC
Affordable pricing
Medical Spa (MedSpa) directors and workers should be aware of the FDA laws and policies that govern their industry, including those of their primary vendors. This rule may serve to warn directors and clinicians in this and other medical practices the risks of working with those compound pharmacies that do not comply.
Compound pharmacies sell clinicians multi-use containers of compounded BLT to be used for many patients but prescribed for one. The legal risk is transferred to the prescriber who ordered the compound not the pharmacy providing it. STOP THE INSANITY! It is your practice and your good name. Here is your fix!
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
2. Background
Clinicians are increasingly using topical
anesthetics to decrease the pain
associated with minimally invasive
dermatologic, aesthetic, injection,
cannulation and laser procedures (among
others).
Numerous lidocaine-containing products
are available, but comprehensive studies
are lacking regarding their relative safety
and appropriate dermatologic uses.
3. Concept
Lidocaine-containing products play an
integral role in cutaneous anesthesia by
providing patient comfort with minimal side
effects. Careful attention must be paid to
the particular anatomic location, the total
surface area covered, active ingredient
concentration and the duration of
anesthetic skin contact.
4. Awareness
Topical anesthetics decrease pain during
superficial cutaneous procedures. As the
number of in-office dermatologic
procedures continues to grow, clinicians
will benefit from awareness of the
indications, pharmacologic mechanisms,
appropriate methods of application, and
safety profiles of the currently available
prescription and over-the-counter (OTC)
topical anesthetics.
5. Mechanism of Action
Once inside the dermis, ester and amide
anesthetics possess the same mechanism
of action. The anesthetic binds the voltage-
gated sodium ion channel of the free nerve
endings and blocks sodium influx. The
blockade of sodium influx inhibits nerve cell
depolarization and prevents propagation of
nerve cell impulses along the nerve. Meechan
JG. Intraoral topical anesthesia. Periodontal 2000 2008;46:6 - 79
6. NeuroMed7® OTC Rapid Onset
Topical Anesthetic can be used
for:
• Superficial aesthetic procedures
• Hair and tattoo removal
• Minimally invasive excisions
• Injections
• Cannulation procedures
• Other minimally invasive procedures
and uses as directed by a licensed
physician
7. Proprietary formulation
• Designed to improve absorption
• Rapid-onset of action – 15 – 20 minutes
• Medium duration of efficacy –
approximately 60 minutes
• Safe and effective
• Patent-pending
8. Designed to improve absorption
• Rapid-onset – 15 to 20 minutes
• Medium duration – 60 minutes
• Safe and effective
• Easy to apply and remove
• Free of oily or gritty residue
9. A time saving & cost effective solution
• Save time - peak onset of action – 15 –
20 minutes
• Save money – only $23 per 2.2 ounce
(63 gram) tube – as low as $19 per tube
for bulk orders
• Increase practice revenue – can be
dispensed as a retail item for clinician-
directed, patient self-application – at
high margins
• Increase efficiency– reduced onset of
action time can increase patient flow
efficiency
10. Proper application
• Clean treatment area with mild cleanser and
damp, clean cloth to remove any dirt, make-
up or other material that may impede
absorption.
• Use approximately a “US quarter
dollar”(or one packet) size amount per
4”x4” area 15 - 20 minutes prior to
procedure (recommended dose – 0.75 –
2.0 grams – or milliliters – per 1”X1”
square area
• Dosage will depend on the skin type,
aggressiveness of procedure, known
patient pain tolerance and surface area.
• Use the least amount of product necessary
to achieve the required amount of local
anesthesia
11. Proper application – cont’d
• Avoid use on open wounds, broken
skin, eyes, ears, in the nostrils and
mouth
• With a gloved hand, evenly distribute
the cream and rub vigorously in a
circular motion for at least 30 – 60
seconds to each area of the
treatment surface
• Apply more aggressively to
known pain-sensitive “hot spot”
areas on the face and body
• The peak action begins in
approximately 15 – 20 minutes
12. Proper application – cont’d
• Some clinicians use an occlusive
dressing for an improved efficacy –
occlusion should be determined by a
licensed physician.
• It is important to note that applying a
hot or warm compress to the treatment
area prior to application of
NeuroMed7® will increase cutaneous
absorption. While this method will
enhance the effect of the anesthetic,
special care should be exercised in
recognition of the potential for
increased systemic entry of the active
ingredient, lidocaine HCL 4%
• Do not exceed 10 grams
(milliliters) per application
• Physician should take into account
total anesthetic dose when using
this product in combination with
other anesthetic products
13. Contact Sambria
Pharmaceuticals or your local
representative
1075 Peachtree Street NE, Suite 3650
Atlanta, Georgia 30309
888.246.6601 | info@sambriapharma.com |
www.sambriapharma.com